Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis

Vet Immunol Immunopathol. 2011 May 15;141(1-2):64-75. doi: 10.1016/j.vetimm.2011.02.007. Epub 2011 Feb 23.

Abstract

In this study, we summarized the major phenotypic/functional aspects of circulating leukocytes following canine immunization with Leishvaccine and Leishmune®. Our findings showed that Leishvaccine triggered early changes in the innate immunity (neutrophils and eosinophils) with late alterations on monocytes. Conversely, Leishmune(®) induced early phenotypic changes in both, neutrophils and monocytes. Moreover, Leishvaccine triggered mixed activation-related phenotypic changes on T-cells (CD4+ and CD8+ and B-lymphocytes, whereas Leishmune(®) promoted a selective response, mainly associated with CD8+ T-cell activation. Mixed cytokine profile (IFN-γ/IL-4) was observed in Leishvaccine immunized dogs whereas a selective pro-inflammatory pattern (IFN-γ/NO) was induced by Leishmune® vaccination. The distinct immunological profile triggered by Leishvaccine and Leishmune® may be a direct consequence of the distinct biochemical composition of these immunobiological, i.e. complex versus purified Leishmania antigen along with Bacillus Calmette-Guérin (BCG) versus saponin adjuvant. Both immunobiologicals are able to activate phagocytes and CD8+ T-cells and therefore could be considered as a putative vaccines against canine visceral leishmaniasis (CVL).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antigens, Protozoan / immunology
  • Cytokines / immunology
  • Dog Diseases / immunology
  • Dog Diseases / parasitology*
  • Dog Diseases / prevention & control
  • Dogs / immunology
  • Dogs / parasitology
  • Female
  • Immunity, Innate / immunology
  • Leishmania infantum / immunology
  • Leishmaniasis Vaccines / immunology
  • Leishmaniasis Vaccines / pharmacology*
  • Leishmaniasis Vaccines / therapeutic use
  • Leishmaniasis, Visceral / immunology
  • Leishmaniasis, Visceral / prevention & control
  • Leishmaniasis, Visceral / veterinary*
  • Leukocytes / immunology*
  • Male
  • Nitric Oxide Synthase / metabolism

Substances

  • Antibodies, Monoclonal
  • Antigens, Protozoan
  • Cytokines
  • Leishmaniasis Vaccines
  • Nitric Oxide Synthase